arrow_back Back Filing freshness 10-Q Q3 FY2022 SEC EDGAR

download Export Data

BetterLife Pharma Inc.

BETRF

— Price unavailable

42 Visible periods

18 Metrics

Absolute Benchmarks

Price Chart

insights

Verdict pending

Sync financial data to generate a health grade for this company.

auto_awesome

Analytical Summary

On an absolute basis, BetterLife Pharma Inc. shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC None

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

42-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-3.38M

↓ -138.8% —

FCF / Share Free cash flow per share

$-0.01

↓ -643.1% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
EPS Growth YoY (%)	—	—	—	N/M	—	—	—	—	—	—	—	—	—	-100.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	—	—	—	N/M	-25358.0% Weak ↓ Weak Declining Year-over-year change in net income	-407.9% Weak ↓ Weak Declining Year-over-year change in net income	59.8% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	99.5% Excellent ↑ Excellent Improving Year-over-year change in net income	90.4% Excellent ↑ Excellent Improving Year-over-year change in net income	88.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-12077.3% Weak ↓ Weak Declining Year-over-year change in net income	50.0% Excellent Excellent Year-over-year change in net income	-185.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—	-891.8% Weak ↓ Weak Declining Year-over-year change in net income	60.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-15.8% Weak Weak Year-over-year change in net income	-167.7% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	67.3% Excellent Excellent Year-over-year change in net income	N/M	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-496.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	-0.6% Weak Weak Year-over-year change in free cash flow	—	—	—	-241.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
FCF / Net Income (x)	—	—	—	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	16.46x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
Return on Invested Capital (%)	—	—	—	-32.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	575.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-79.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	44.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	46.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	132.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	517.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	1630.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	—	—	—	-19.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-86.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-690.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-430.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-619.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-301.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6685.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6067.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6400.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	—	—	-98.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-757%)	-42.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-386%)	-35.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	—	290.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1834%)	0.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	18.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+23%)	55.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+267%)	82.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+448%)	167.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1016%)	—	—	—	—	—	—	—	—	—	—	78.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+421%)	6.9% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	—	—	9.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	22.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+48%)	—	93.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+525%)	—	—	—	286.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1811%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
Interest Coverage (x)	—	—	—	-10.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.18x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-113.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-29.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-102.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	-191.11x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	$-406.90K	$-474.49K	$-1.51M	$-64.51K	$-250.39K	$-9.94K	$-46.70K	$-112.42K	$-206.57K	$-3.05K	$-29.44K	$-71.64K	$-143.64K	$-207.50K	$-28.04K	$-839.00	—	—	—	$-935.00	$-8.32K	$-961.00	$-15.14K	$-475.00	$-1.29K	$-1.84K	$-3.49K	$-2.06K	$-5.53K	$-18.91K	$-58.54K	$-15.04K	$-1.90K	$-18.98K	$-18.98K	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
Basic EPS, GAAP (USD)	—	—	—	$-0.04	—	—	—	$0.01	—	—	—	—	—	$-0.04	—	—	—	$-0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	$-0.01	—	—	—	—	—	—	—	—	—	$-0.00	—	—	—	$-0.00	—	—	—	—	—	—	$-0.00	$-0.01	—	—	—	$-0.01	—	$-0.00	$0.00	$-0.00	—	—	—	—	—	—	—	—
Book Value per Share (USD)	—	—	—	$0.04	$0.04	$0.05	$-0.00	$0.00	$-0.02	$-0.02	$-0.02	$-0.02	$-0.01	$-0.01	$-0.00	—	—	—	$-0.00	—	—	—	—	—	$-0.02	$-0.02	—	$-0.02	$-0.02	$-0.01	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	—	—	—	$0.04	$0.04	$0.05	$-0.00	$0.00	$-0.02	$-0.02	$-0.02	$-0.02	$-0.01	$-0.01	$-0.00	—	—	—	$-0.00	—	—	—	—	—	$-0.02	$-0.02	—	$-0.02	$-0.02	$-0.01	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	99.54M	—	89.62M	—	—	—	—	—	—	—	—	—	74.84M	—	—	—	72.65M	—	115.77M	115.77M	101.44M	—	—	35.77M	35.77M	—	35.77M	35.77M	35.77M	—	35.35M	33.79M	33.62M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
Working Capital (USD)	—	—	—	$-3.09M	—	—	—	$145.89K	$-1.29M	$-1.74M	—	$-1.16M	$-707.34K	$-511.78K	$-331.89K	—	—	—	—	—	—	—	—	$-704.06K	$-686.00K	$-638.61K	$-657.58K	$-582.27K	$-521.11K	$-391.20K	$-864.20K	—	—	—	$-111.89K	—	—	—	—	—	—	—
Total Equity (USD)	—	—	—	$3.43M	$3.30M	$4.59M	$-45.38K	$182.94K	$-1.28M	$-1.73M	$-1.47M	$-1.16M	$-704.44K	$-508.88K	$-328.99K	—	—	—	$-54.52K	—	—	—	$-672.01K	$-770.39K	$-693.86K	$-645.65K	$-674.64K	$-613.22K	$-552.57K	$-429.66K	$-1.02M	—	—	—	$-1.02M	—	—	$-2.95M	$29.72K	$166.01K	$166.01K	$0.00

📋 What is driving earnings? 2 metrics

Metric	Q3 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2020 Apr 30, 2019 10-Q ↗	Q4 FY2019 Jan 31, 2019 10-Q ↗	Q3 FY2019 Oct 31, 2018 10-Q ↗	Q2 FY2019 Jul 31, 2018 10-Q ↗	Q1 FY2019 Apr 30, 2018 10-Q ↗	Q4 FY2018 Jan 31, 2018 10-K ↗	Q3 FY2018 Oct 31, 2017 10-Q ↗	Q2 FY2018 Jul 31, 2017 10-Q ↗	Q1 FY2018 Apr 30, 2017 10-Q ↗	Q4 FY2017 Jan 31, 2017 10-K ↗	Q3 FY2017 Oct 31, 2016 10-Q ↗	Q2 FY2017 Jul 31, 2016 10-Q ↗	Q1 FY2017 Apr 30, 2016 10-Q ↗	Q4 FY2016 Jan 31, 2016 10-K ↗	Q3 FY2016 Oct 31, 2015 10-Q ↗	Q2 FY2016 Jul 31, 2015 10-Q ↗	Q1 FY2016 Apr 30, 2015 10-Q ↗	Q4 FY2015 Jan 31, 2015 10-K ↗	Q3 FY2015 Oct 31, 2014 10-Q ↗	Q2 FY2015 Jul 31, 2014 10-Q ↗	Q1 FY2015 Apr 30, 2014 10-Q ↗	Q4 FY2014 Jan 31, 2014 10-K ↗	Q3 FY2014 Oct 31, 2013 10-Q ↗	Q2 FY2014 Jul 31, 2013 10-Q ↗	Q1 FY2014 Apr 30, 2013 10-Q ↗	Q4 FY2013 Jan 31, 2013 10-K ↗	Q3 FY2013 Oct 31, 2012 10-Q ↗	Q2 FY2013 Jul 31, 2012 10-Q ↗	Q1 FY2013 Apr 30, 2012 10-Q ↗	Q4 FY2012 Jan 31, 2012 10-K ↗	Q3 FY2012 Oct 31, 2011 10-Q ↗	Q2 FY2012 Jul 31, 2011 10-Q ↗	Q1 FY2012 Apr 30, 2011 10-Q ↗	Q4 FY2011 Jan 31, 2011 10-K ↗	Q3 FY2011 Oct 31, 2010 10-Q ↗	Q1 FY2011 Jan 31, 2010 10-Q ↗	Q4 FY2010 Jan 31, 2010 10-K ↗	Q4 FY2009 Jan 31, 2009 10-K ↗	Q4 FY2008 Jan 31, 2008 10-K ↗	Q4 FY2007 Jan 31, 2007 10-K ↗	Q4 FY2002 Jun 9, 2002 10-K ↗
Net Income, GAAP (USD)	—	—	—	$-3.38M	$-1.41M	$-1.62M	$-326.54K	$530.73K	$-5.56K	$-319.81K	$-812.05K	$-954.94K	$-1.18M	$-3.33M	$-6.79M	$-7.84K	$-2.36M	$-1.17M	—	—	—	—	—	$-601.53K	$-48.20K	$-2.21M	$-2.57M	$-60.65K	$-122.92K	$-1.91M	$-960.35K	$129.57K	$133.62K	$2.11M	$-2.93M	$-20.19K	—	—	—	—	—	—
Operating Cash Flow (USD)	—	—	—	$-705.89K	$-982.80K	$-1.87M	$-195.89K	—	—	$-67.98K	$-99.62K	—	—	$-79.33K	$-124.00	$-129.07K	$-21.84K	$-12.90K	—	—	—	—	—	$-5.84K	$-20.20K	$-528.02K	$-496.92K	—	—	$-524.68K	$-3.46K	$-13.38K	$25.37K	$-144.37K	$-49.95K	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 14 years · 42 quarters

BetterLife Pharma Inc.

Analytical Summary

42-Year Financial Trajectory

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare BETRF with peers